AVN-322 free base structure
|
Common Name | AVN-322 free base | ||
|---|---|---|---|---|
| CAS Number | 1194574-33-8 | Molecular Weight | 357.432 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H19N5O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AVN-322 free baseA highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia; significantly restores both scopolamine- and MK-801-induced cognitive dysfunction and demonstrates antipsychotic potential. Alzheimer Disease Phase 2 Clinical |
| Name | AVN-322 free base |
|---|
| Description | A highly selective, potent, BBB penetrant and orally bioavailable 5-HT6R antagonist for the treatment of neurological disorders such as AD and schizophrenia; significantly restores both scopolamine- and MK-801-induced cognitive dysfunction and demonstrates antipsychotic potential. Alzheimer Disease Phase 2 Clinical |
|---|---|
| References | References 1. Ivachtchenko AV, et al. Curr Alzheimer Res. 2017;14(3):268-294. View Related Products by Target 5-HT Receptor Alzheimer Disease |
| Molecular Formula | C17H19N5O2S |
|---|---|
| Molecular Weight | 357.432 |
| InChIKey | OSHBEPOEBKFEEK-UHFFFAOYSA-N |
| SMILES | CNc1nn2c3c(cnc2c1S(=O)(=O)c1ccccc1)CN(C)CC3 |